Physician profile
Lydia Carpenter
NPI 1972594893
$470.38
in general payments reported to CMS, 2019-2025
9 companies · $48.42 in 2025
The $48.42 reported for 2025 was less than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $37.87 · 2022: $59.48 · 2023: $295 · 2024: $29.16 · 2025: $48.42.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $373.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $373.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $164.98 | 2023-2024 | Sotyktu |
| Ucb, INC. | $93.37 | 2023 | Bimzelx |
| Incyte Corporation | $52.08 | 2023 | Opzelura |
| Abbvie INC. | $47.21 | 2022-2025 | |
| Allergan, INC. | $46.02 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $23.61 | 2019 | |
| Xeris Pharmaceuticals, INC. | $14.67 | 2025 | Gvoke Hypopen |
| Pfizer INC. | $14.26 | 2019 | |
| Dermavant Sciences, INC. | $14.18 | 2024 | Vtama |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lydia Carpenter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.